Clinical trial
Novel Drug Delivery Technique for Glaucoma Patients
NCT02051946 is registered in ClinicalTrials.gov with Molly Walsh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Drug Delivery Technique for Glaucoma Patients
- Lead sponsor
- Molly Walsh
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- May 31, 2014
- Completion date
- October 31, 2015
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.